Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Percutaneous Coronary Intervention with Stenting versus Coronary Artery Bypass Grafting in Stable Coronary Artery
Ian C Glenn1, Gabriele M Iacona2, Abeel A Mangi2
1Department of Thoracic and Cardiovascular Surgery; Heart, Vascular, and Thoracic Institute; Cleveland Clinic; Cleveland, Ohio.
Insights
Coronary artery bypass grafting (CABG) offers better survival and fewer repeat procedures than percutaneous coronary intervention (PCI) for stable multivessel coronary artery disease. However, PCI has lower cerebrovascular event rates, highlighting ongoing treatment considerations.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- The optimal revascularization strategy for stable multivessel coronary artery disease (CAD) remains a subject of ongoing clinical debate.
- Numerous studies have compared coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) with stent placement, yet definitive conclusions are still sought.
Purpose of the Study:
- To review recent randomized control trials (RCTs) and meta-analyses of pooled RCT data.
- To provide an updated comparison of CABG versus PCI for stable multivessel CAD.
- To inform clinical decision-making regarding revascularization strategies.
Main Methods:
- Systematic review of recent randomized control trials (RCTs).
- Meta-analysis of pooled RCT data.
- Comparative analysis of clinical outcomes between CABG and PCI.
Main Results:
- CABG demonstrated superiority in reducing all-cause mortality and the need for repeat revascularization.
- These benefits of CABG were more pronounced in patients with multivessel CAD and diabetes, and less evident in left main CAD.
- PCI consistently showed a lower incidence of cerebrovascular events compared to CABG.
Conclusions:
- Despite advancements in drug-eluting stent technology, CABG retains significant advantages over PCI for stable multivessel CAD.
- Further research is needed to establish optimal endpoints for comparing PCI and CABG.
- Refining patient selection criteria for both interventions is crucial for personalized treatment strategies.
Abstract:
The debate over coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) with stent placement for the treatment of stable multivessel coronary artery disease (CAD) continues in spite of numerous studies investigating the issue. This paper reviews the most recent randomized control trials (RCT) and meta-analyses of pooled RCT data to help address this issue. General trends demonstrated that CABG was superior in all-cause mortality and fulfilling the need for repeat revascularization. These advantages tended to be more pronounced in multivessel CAD and diabetes, and less so in left main CAD. PCI showed a consistently lower rate of cerebrovascular events. CABG continues to offer significant advantages over PCI, even as drug-eluting stent technology continues to evolve. The ideal endpoint for comparing PCI and CABG remains to be determined. Furthermore, additional research is required to further refine patient selection criteria for each intervention.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
12:00Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Angina II: Classification